Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Oncotelic Therapeutics, Inc. (OTLC)

0.0600
+0.0070
+(13.21%)
As of May 5 at 4:00:00 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
70
--
--
Operating Expense
376.0130
376.0130
634.8690
5,610.5740
9,125.8830
Operating Income
-376.0130
-376.0130
-564.8690
-5,610.5740
-9,125.8830
Net Non Operating Interest Income Expense
-857.7230
-857.7230
-1,044.7860
-2,971.0460
-2,002.8130
Other Income Expense
-3,545.7230
-3,545.7230
-6,596.4100
13,258.2230
611.4060
Pretax Income
-4,779.4590
-4,779.4590
-8,206.0650
4,676.6030
-10,517.2900
Net Income Common Stockholders
-4,523.9320
-4,523.9320
-7,903.0930
5,094.9810
-9,391.0420
Diluted NI Available to Com Stockholders
-4,523.9320
-4,523.9320
-7,903.0930
5,094.9810
-9,391.0420
Basic EPS
-0.01
-0.01
-0.02
0.01
-0.03
Diluted EPS
-0.01
-0.01
-0.02
0.01
-0.03
Basic Average Shares
402,308.5260
404,396.4730
384,075.3690
384,075.3690
303,078.5480
Diluted Average Shares
402,308.5260
404,396.4730
384,075.3690
457,299.8900
303,078.5480
Total Operating Income as Reported
-3,576.0130
-3,576.0130
-6,648.0150
-9,721.6530
-9,125.8830
Total Expenses
376.0130
376.0130
634.8690
5,610.5740
9,125.8830
Net Income from Continuing & Discontinued Operation
-4,523.9320
-4,523.9320
-7,903.0930
5,094.9810
-9,391.0420
Normalized Income
-955.2720
-955.2720
-1,234.4370
-4,957.5620
-10,002.4480
Interest Expense
857.7230
857.7230
1,044.7860
2,971.0460
2,002.8130
Net Interest Income
-857.7230
-857.7230
-1,044.7860
-2,971.0460
-2,002.8130
EBIT
-3,921.7360
-3,921.7360
-7,161.2790
7,647.6490
-8,514.4770
EBITDA
-3,921.7360
-3,921.7360
-7,161.2790
7,660.4900
-8,452.9640
Reconciled Depreciation
--
--
--
12.8410
61.5130
Net Income from Continuing Operation Net Minority Interest
-4,523.9320
-4,523.9320
-7,903.0930
5,094.9810
-9,391.0420
Total Unusual Items Excluding Goodwill
-3,568.6600
-3,568.6600
-6,668.6560
12,724.7380
611.4060
Total Unusual Items
-3,568.6600
-3,568.6600
-6,668.6560
12,724.7380
611.4060
Normalized EBITDA
-353.0760
-353.0760
-492.6230
-5,064.2480
-9,064.3700
Tax Rate for Calcs
--
--
--
0.0002
--
Tax Effect of Unusual Items
--
--
--
2,672.1950
--
12/31/2021 - 8/26/1993

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RAONF Race Oncology Limited
1.2200
0.00%
 
RMTG Regenerative Medical Technology Group Inc.
0.0400
0.00%
 
TGRP TRON Group Inc.
0.0350
0.00%
 
CPMV Mosaic ImmunoEngineering, Inc.
0.7480
+24.25%
 
INTI Inhibitor Therapeutics, Inc.
0.0500
0.00%
 
CLCS Cell Source, Inc.
0.2750
-5.17%
 
IMUC EOM Pharmaceuticals Holdings, Inc.
0.0950
0.00%
 
AMBS Amarantus BioScience Holdings, Inc.
0.0003
0.00%
 
USRM U.S. Stem Cell, Inc.
0.0002
0.00%
 
ARDS Aridis Pharmaceuticals, Inc.
0.0001
0.00%